Gallbladder Polyp Evaluation Guidelines

Essential Risk Stratification Factors

The Society of Radiologists in Ultrasound consensus determined that age alone should not influence polyp risk stratification 1
Primary sclerosing cholangitis is a critical risk factor with malignancy rates of 18-50% in patients with polyps 2
Primary sclerosing cholangitis creates a biliary epithelium field defect that dramatically increases malignant transformation risk 2
North/South American Indigenous populations and North Indian populations have the highest incidences of gallbladder carcinoma 2

The presence of coexisting gallstones may be considered in overall clinical decision-making, although they do not independently influence polyp risk stratification per SRU guidelines 1
Diabetes mellitus is associated with a relative risk of 1.97 for gallbladder cancer 1
Smoking is associated with a relative risk of 1.25 for gallbladder cancer 1
Obesity is associated with a relative risk of 1.31, particularly in premenopausal women 1
These factors increase relative risk but do not sufficiently increase absolute risk to change management recommendations 1

Surgical morbidity is 2-8% and mortality is 2-7 per 1000 patients 3
Postoperative morbidity and mortality increase with age and frailty, requiring careful shared decision-making 1
The risk of bile duct injury is 3-6 per 1000 patients, which must be weighed against malignancy risk 3
Growth of ≥4 mm within 12 months constitutes rapid growth requiring surgical consultation 4, 5, 3
Growth up to 3 mm may be part of the natural history of benign polyps 5

Gallstones should not be over-emphasized, as their presence does not change polyp risk stratification 1
Patient age alone should not drive decisions, while important for surgical risk, it should not influence polyp risk categorization 1
It should be remembered that 61-69% of polyps seen on ultrasound are not found at cholecystectomy, particularly those ≤5 mm (up to 83% not found) 1, 3